Y-Intercept (HK)’s Amicus Therapeutics FOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.65M Buy
986,779
+965,328
+4,500% +$5.53M 0.14% 184
2025
Q1
$175K Sell
21,451
-99,507
-82% -$812K 0.01% 1073
2024
Q4
$1.14M Buy
120,958
+85,951
+246% +$810K 0.08% 375
2024
Q3
$374K Sell
35,007
-68,109
-66% -$727K 0.02% 918
2024
Q2
$1.02M Buy
103,116
+35,875
+53% +$356K 0.06% 483
2024
Q1
$792K Buy
+67,241
New +$792K 0.06% 483
2023
Q4
Sell
-24,170
Closed -$294K 1375
2023
Q3
$294K Sell
24,170
-11,554
-32% -$140K 0.03% 781
2023
Q2
$449K Buy
35,724
+20,168
+130% +$253K 0.05% 597
2023
Q1
$173K Sell
15,556
-54,651
-78% -$606K 0.02% 998
2022
Q4
$857K Buy
70,207
+21,708
+45% +$265K 0.13% 248
2022
Q3
$506K Buy
48,499
+29,483
+155% +$308K 0.05% 535
2022
Q2
$204K Buy
+19,016
New +$204K 0.03% 681
2022
Q1
Sell
-17,431
Closed -$201K 796
2021
Q4
$201K Buy
+17,431
New +$201K 0.05% 517
2021
Q3
Sell
-16,435
Closed -$158K 734
2021
Q2
$158K Sell
16,435
-45,637
-74% -$439K 0.04% 547
2021
Q1
$583K Buy
62,072
+47,475
+325% +$446K 0.16% 206
2020
Q4
$335K Buy
+14,597
New +$335K 0.14% 274